{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:46:40Z","timestamp":1791996400272,"version":"4.4.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022CR81, 2024IR35, 2022CR41"],"award-info":[{"award-number":["2022CR81, 2024IR35, 2022CR41"]}]},{"name":"National Key Research and Development Program of China","award":["2024YFC2511000"],"award-info":[{"award-number":["2024YFC2511000"]}]},{"name":"Innovative Research Group Project of the National Natural Science Foundation of China","award":["82370709, 82570833, 92478202, 22321005"],"award-info":[{"award-number":["82370709, 82570833, 92478202, 22321005"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,6]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n Genetic variant rs477155 near cytidine deaminase identified IgA nephropathy patients with enhanced glucocorticoid response.<\/jats:p>\n <\/jats:list-item>\n \n \n rs477155 may regulate cytidine deaminase\n via<\/jats:italic>\n glucocorticoid receptor, linking genomic variation to steroid sensitivity and individualized treatment optimization.\n <\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Glucocorticoid therapy improves outcomes in high-risk IgA nephropathy but shows variable efficacy and adverse effects, potentially influenced by genetic factors.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n We conducted a genome-wide pharmacogenomic analysis in 260 biopsy-confirmed patients with IgA nephropathy from the Chinese The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) study cohort (134 received methylprednisolone and 126 received placebo), assessing the percentage reduction in 24-hour proteinuria at 6 months\n via<\/jats:italic>\n genotype-by-treatment interaction models. Replication was performed in an independent cohort of 211 high-risk patients receiving glucocorticoid monotherapy. Functional annotation, expression quantitative trait loci mapping, regulatory analyses, and dual-luciferase reporter assays elucidated the biologic relevance of candidate loci.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Genome-wide analysis identified three loci with suggestive genotype-by-treatment interaction (\n P<\/jats:italic>\n < 5.00\u00d710\n \u22126<\/jats:sup>\n ), of which rs477155 (chromosome 1, intronic to cytidine deaminase [\n CDA<\/jats:italic>\n ]) was replicated in the independent cohort (discovery\n P<\/jats:italic>\n = 2.70\u00d710\n \u22126<\/jats:sup>\n , replication\n P<\/jats:italic>\n = 0.01). In the TESTING study cohort, carriers of the rs477155 GG genotype had significantly higher rates of complete proteinuria remission (odds ratio, 2.5; 95% confidence interval, 1.3 to 4.9;\n P<\/jats:italic>\n = 5.00\u00d710\n \u22123<\/jats:sup>\n ) and composite clinical remission (odds ratio, 2.8; 95% confidence interval, 1.6 to 4.9;\n P<\/jats:italic>\n = 3.13\u00d710\n \u22124<\/jats:sup>\n ) at 6 months. Functional analyses revealed that rs477155 acts as a\n Cis<\/jats:italic>\n -expression quantitative trait locus for\n CDA<\/jats:italic>\n in blood and immune cells and is located within an enhancer region marked by H3K4Me1\/H3K27Ac and a glucocorticoid receptor (nuclear receptor subfamily 3 group C member 1 [NR3C1])\u2013binding site. Bioinformatics, dual-luciferase reporter assay, and RNA-seq analyses indicated that NR3C1 may directly regulate\n CDA<\/jats:italic>\n expression, with rapid upregulation of\n CDA<\/jats:italic>\n observed in blood after dexamethasone stimulation (9.84\u00b10.52 versus 10.50\u00b10.55,\n P<\/jats:italic>\n = 7.41\u00d710\n \u221223<\/jats:sup>\n ). Phenome-wide association studies further linked rs477155 and\n CDA<\/jats:italic>\n to a spectrum of immune and kidney traits, including acute tubulointerstitial nephritis (\n P<\/jats:italic>\n = 7.4\u00d710\n \u221211<\/jats:sup>\n ), nephritic syndrome (\n P<\/jats:italic>\n = 2.7\u00d710\n \u22128<\/jats:sup>\n ), asthma (\n P<\/jats:italic>\n = 2.5\u00d710\n \u221221<\/jats:sup>\n ), and rheumatoid arthritis (\n P<\/jats:italic>\n = 2.1\u00d710\n \u221212<\/jats:sup>\n ).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n In this study, rs477155 was suggestively associated with glucocorticoid responsiveness in IgA nephropathy, potentially\n via<\/jats:italic>\n a suggested NR3C1-regulated\n CDA<\/jats:italic>\n pathway.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1681\/asn.0000000977","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T17:00:27Z","timestamp":1765472427000},"page":"1248-1260","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Genetic Determinants of Steroid Responsiveness in IgA Nephropathy"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1434-4944","authenticated-orcid":false,"given":"Lin-lin","family":"Xu","sequence":"first","affiliation":[{"name":"Renal Division, Peking University First Hospital, Kidney Genetics Center, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7215-707X","authenticated-orcid":false,"given":"Xu-jie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Kidney Genetics Center, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5108-9311","authenticated-orcid":false,"given":"Wenjian","family":"Bi","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, School of Basic Medical Sciences, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1742-1680","authenticated-orcid":false,"given":"Peipei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-7054","authenticated-orcid":false,"given":"Su-fang","family":"Shi","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Kidney Genetics Center, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2803-6956","authenticated-orcid":false,"given":"Li-jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Kidney Genetics Center, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-cheng","family":"Lv","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Kidney Genetics Center, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9855-4068","authenticated-orcid":false,"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Kidney Genetics Center, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"245","key":"B1-20261014","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/oxfordjournals.qjmed.a068143","article-title":"The commonest glomerulonephritis in the world: IgA nephropathy","volume":"64","author":"D'Amico","year":"1987","journal-title":"Q J Med."},{"issue":"1","key":"B2-20261014","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0002-9343(88)90019-8","article-title":"IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?","volume":"84","author":"Julian","year":"1988","journal-title":"Am J Med."},{"issue":"10","key":"B3-20261014","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","article-title":"IgA nephropathy","volume":"347","author":"Donadio","year":"2002","journal-title":"New Engl J Med."},{"issue":"10032","key":"B4-20261014","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(16)00272-5","article-title":"Primary glomerulonephritides","volume":"387","author":"Floege","year":"2016","journal-title":"Lancet."},{"issue":"2","key":"B5-20261014","first-page":"172","article-title":"Incidence of adult primary immunoglobulin A nephropathy among a racially\/ethnically diverse population in the United States","volume":"56","author":"Sim","year":"2025","journal-title":"Am J Nephrol."},{"issue":"5","key":"B6-20261014","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ki.2015.252","article-title":"New developments in the genetics, pathogenesis, and therapy of IgA nephropathy","volume":"88","author":"Magistroni","year":"2015","journal-title":"Kidney Int."},{"issue":"19","key":"B7-20261014","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.2022.5368","article-title":"Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial","volume":"327","author":"Lv","year":"2022","journal-title":"JAMA."},{"issue":"23","key":"B8-20261014","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"New Engl J Med."},{"issue":"4S","key":"B9-20261014","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int."},{"issue":"11","key":"B10-20261014","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrendo.2013.183","article-title":"Glucocorticoid sensitivity in health and disease","volume":"9","author":"Quax","year":"2013","journal-title":"Nat Rev Endocrinol."},{"issue":"11","key":"B11-20261014","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3390\/cells10113186","article-title":"NR3C1 glucocorticoid receptor gene polymorphisms are associated with membranous and IgA nephropathies","volume":"10","author":"Pac","year":"2021","journal-title":"Cells."},{"issue":"11","key":"B12-20261014","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3118","article-title":"Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet."},{"issue":"11","key":"B13-20261014","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.686","article-title":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index","volume":"42","author":"Speliotes","year":"2010","journal-title":"Nat Genet."},{"issue":"1","key":"B14-20261014","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","article-title":"GCTA: a tool for genome-wide complex trait analysis","volume":"88","author":"Yang","year":"2011","journal-title":"Am J Hum Genet."},{"issue":"10","key":"B15-20261014","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/bioinformatics\/btw018","article-title":"FINEMAP: efficient variable selection using summary data from genome-wide association studies","volume":"32","author":"Benner","year":"2016","journal-title":"Bioinformatics."},{"issue":"7","key":"B16-20261014","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41588-023-01422-x","article-title":"Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy","volume":"55","author":"Kiryluk","year":"2023","journal-title":"Nat Genet."},{"issue":"2","key":"B17-20261014","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s43657-023-00138-6","article-title":"Clinical application of polygenic risk score in IgA nephropathy","volume":"4","author":"Xu","year":"2024","journal-title":"Phenomics."},{"issue":"Database issue","key":"B18-20261014","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants","volume":"40","author":"Ward","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"B19-20261014","doi-asserted-by":"crossref","first-page":"D983","DOI":"10.1093\/nar\/gkz888","article-title":"QTLbase: an integrative resource for quantitative trait loci across multiple human molecular phenotypes","volume":"48","author":"Zheng","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"B20-20261014","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/bioinformatics\/btab614","article-title":"FIVEx: an interactive eQTL browser across public datasets","volume":"38","author":"Kwong","year":"2022","journal-title":"Bioinformatics."},{"issue":"9","key":"B21-20261014","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat Genet."},{"issue":"7414","key":"B22-20261014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature."},{"issue":"7818","key":"B23-20261014","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","article-title":"Expanded encyclopaedias of DNA elements in the human and mouse genomes","volume":"583","author":"Moore","year":"2020","journal-title":"Nature."},{"issue":"D1","key":"B24-20261014","doi-asserted-by":"crossref","first-page":"D1243","DOI":"10.1093\/nar\/gkae974","article-title":"The UCSC genome browser database: 2025 update","volume":"53","author":"Perez","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"B25-20261014","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","article-title":"hTFtarget: a comprehensive database for regulations of human transcription factors and their targets","volume":"18","author":"Zhang","year":"2020","journal-title":"Genomics Proteomics Bioinformatics."},{"issue":"D1","key":"B26-20261014","doi-asserted-by":"crossref","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","article-title":"Jaspar 2024: 20th anniversary of the open-access database of transcription factor binding profiles","volume":"52","author":"Rauluseviciute","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"B27-20261014","doi-asserted-by":"crossref","first-page":"D61","DOI":"10.1093\/nar\/gkad1069","article-title":"Cistrome data browser: integrated search, analysis and visualization of chromatin data","volume":"52","author":"Taing","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"B28-20261014","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"B29-20261014","doi-asserted-by":"crossref","first-page":"D1056","DOI":"10.1093\/nar\/gky1133","article-title":"Open targets platform: new developments and updates two years on","volume":"47","author":"Carvalho-Silva","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"B30-20261014","doi-asserted-by":"crossref","first-page":"W305","DOI":"10.1093\/nar\/gkac289","article-title":"ExPheWas: a platform for cis-mendelian randomization and gene-based association scans","volume":"50","author":"Legault","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"7877","key":"B31-20261014","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","article-title":"Rare variant contribution to human disease in 281,104 UK Biobank exomes","volume":"597","author":"Wang","year":"2021","journal-title":"Nature."},{"issue":"4","key":"B32-20261014","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/tpj.2016.34","article-title":"Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies","volume":"17","author":"Tonk","year":"2017","journal-title":"Pharmacogenomics J."},{"issue":"3","key":"B33-20261014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000502327","article-title":"The association of glomerular glucocorticoid receptor expression with responsiveness to corticosteroid treatment in IgA nephropathy","volume":"50","author":"Kee","year":"2019","journal-title":"Am J Nephrol."},{"issue":"6","key":"B34-20261014","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/ki.2013.531","article-title":"Genetic and in vivo determinants of glucocorticoid sensitivity in relation to clinical outcome of childhood nephrotic syndrome","volume":"85","author":"Teeninga","year":"2014","journal-title":"Kidney Int."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:00:15Z","timestamp":1791993615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000000977","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"2025-07-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}